Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang+7 more
wiley +1 more source
Preadmission CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores on Diastolic Function and Functional Outcome After Stroke with Nonvalvular Atrial Fibrillation. [PDF]
Choi JS, Park JH.
europepmc +1 more source
Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function [PDF]
Salvatore Marchì
openalex +1 more source
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu+3 more
wiley +1 more source
Ecocardiografia e função diastólica Echocardiography and diastolic function
Rubens S. Thevenard
doaj +1 more source
A Pilot Study Assessing Left Ventricle Diastolic Function in the Parasternal Long-axis View. [PDF]
Murat Yazici M+5 more
europepmc +1 more source
2D/3D CMR tissue tracking versus CMR tagging in the assessment of spontaneous T2DM rhesus monkeys with isolated diastolic dysfunction [PDF]
et al,, Zheng, Jie
core +1 more source
Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs [PDF]
Peili Zhu+4 more
openalex +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler+4 more
wiley +1 more source